Method of classifying gene expression strength in lung...

Details Method of classifying gene expression strength in lung... Method of classifying gene expression strength in lung...

2004-12-10

2010-12-21

Zeman, Mary K (Department: 1631)

Data processing: measuring, calibrating, or testing

Measurement system in a specific environment

Biological or biochemical

C703S011000, C435S006120, C436S501000

Reexamination Certificate

active

07856318

ABSTRACT:
The present invention provides a method of confirming the gene expression, useful in the decision of a five year survival rate of a patient with lung cancer and the use of a DNA probe kit in the method.A method useful in the decision of a survival rate of a patient with non-small cell lung cancer comprising confirming the expression strength of at least one gene selected from the group consisting ofin lung cancer tissues isolated from the patient.

REFERENCES:
patent: 6812339 (2004-11-01), Venter et al.
patent: 2003/0219760 (2003-11-01), Gordon et al.
patent: 2009/0104617 (2009-04-01), Gordon et al.
patent: WO 02/44331 (2002-06-01), None
patent: WO 2004/005891 (2004-01-01), None
patent: WO2006053442 (2006-01-01), None
Yoshida et al, “The clinical significance of Cyclin B1 and Weel expression in non-small-cell lung cancer”; Annals of Oncology; Official Journal of the European Society for Medical Oncology; Feb. 2004; pp. 252-256.
Wigle et al. “Molecular profiling of non-small cell lung cancer and correlation with disease-free survival”; Cancer Research, American Association for Cancer Research; Jun. 1, 2002; vol. 62, No. 11.
Han et al., “Prognostic value of immunohistochemical expression of p53, HER-2
eu, and bcl-2 in stage 1 non-small-cell lung cancer”, Human Pathology, Jan. 2002; vol. 33, No. 1 pp. 105-110.
Horio et al. “Prognositc significance in p53 mutations and 3p deletion in primary resected non-small cell lung cancer”; Cancer Research; Jan. 1, 1993; pp. 1-4.
Ginsberg et al. “Non-small cell lung cancer” Cancer of the Lung; Chapter 30.2; pp. 858-911.
Moldvay J et al: “P53 expression in stage I squamous cell lung cancer.” Pathology Oncology Research; 1998, vol. 4, No. 1, 1998, pp. 8-13, XP002431203.
Volm M et al: “Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer,” International Journal of Cancer. Journal International DU Cancer Feb. 20, 1997, vol. 74, No. 1, Feb. 20, 1997, pp. 64-68, XP 002431300.
European Search Report dated May 14, 2007.
Dennis A. Wigle, et al., “Molecular Profiling of Non-Small Cell Lung Cancer and Correlation with Disease-free Survival”, Cancer Research, vol. 62, pp. 3005-3008, Jun. 1, 2002.
Ganbunshi Hyouteki Chiryou, vol. 1, No. 1, pp. 72-77, Jan. 30, 2003.
T.R. Golub, et al., “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring”, Science, vol. 286, pp. 531-537, Oct. 15, 1999.
Japanese Office Action dated May 19, 2009 in JP 2003-415,119.

Affiliated with

Also associated with

Rating

Method of classifying gene expression strength in lung... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of classifying gene expression strength in lung..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of classifying gene expression strength in lung... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4183490